In examining recent analyst actions, we gain insights into how financial experts perceive Humana. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings ...

The firm has an Outperform rating on Humana. The Fly notes that back in October, Humana sued U.S. health agencies seeking to reverse a cut to crucial Medicare quality ratings, which translates to ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Humana (HUM – Research Report) and Acumen Pharmaceuticals ...

Morgan Stanley raised the firm’s price target on Humana (HUM) to $290 from $285 and keeps an Equal Weight rating on the shares. While policy ...

Humana's stock has shown resilience, boosted by a 5% increase in Medicare Advantage payments. Read my analysis of HUM stock.

Click here for access. * An analyst from Morgan Stanley persists with their Equal-Weight rating on Humana, maintaining a target price of $285. * An analyst from JP Morgan persists with their ...

UnitedHealth (UNH) stock and Alignment Healthcare (ALHC) stock wins top picks at Baird, which says managed care is a “tariff ...

Baxter covers the Healthcare sector, focusing on stocks such as UnitedHealth, CVS Health, and Humana. Currently, the analyst consensus on Humana is a Moderate Buy with an average price target of ...

In contrast, the analysts noted that Humana, along with Elevance Health ... Deutsche Bank maintained a Buy rating on UnitedHealth shares amid an update on a longstanding Department of Justice ...

Detailed price information for Unitedhealth Group Inc (UNH-N) from The Globe and Mail including charting and trades.